Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity

被引:131
|
作者
Feng, HP [1 ]
Zeng, Y [1 ]
Whitesell, L [1 ]
Katsanis, E [1 ]
机构
[1] Univ Arizona, Steele Mem Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA
关键词
D O I
10.1182/blood.V97.11.3505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In attempting to develop effective anticancer immunotherapies, the relative ability of apoptotic cells to induce an immune response remains an important but controversial consideration. A novel gene-transfer approach was used by which rapid induction of pure apoptosis can be selectively achieved in a transfected tumor cell population following exposure to a semisynthetic dimerizing ligand, AP20187, Inoculation of BALB/c mice with apoptotic and viable 12B1-D1 leukemia cells, at a 12:1 ratio subcutaneously, led to early tumor growth. Heat stress upregulated the expression of membrane heat shock proteins (HSP72 and HSP60) on apoptotic 12B1-D1 cells, and stressed apoptotic cells were capable of generating a T-cell-mediated specific antitumor response. Pulsing of stressed apoptotic leukemia cells onto syngeneic dendritic cells resulted largely in rejection of coinjected viable 12B1-D1 cells. Mice rejecting the primary 12B1-D1 inoculum were immune to the same but not to a different leukemia challenge, Our findings indicate that tumor immunogenicity is dependent on whether cells are stressed before apoptosis induction and suggest that the immune system is capable of distinguishing between stressed and nonstressed cells undergoing programmed cell death.(Blood.2001;97:3505-3512) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:3505 / 3512
页数:8
相关论文
共 50 条
  • [41] Intralesional dendritic cells express B7-H1 in mycosis fungoides, a suppressive signal for tumor-specific immunity?
    Cheng, W
    Zou, W
    Motra, P
    Gilliam, AC
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A118 - A118
  • [42] MEDIATION OF HUMAN TUMOR-SPECIFIC IMMUNITY INVITRO WITH RNA
    WANG, BS
    MANNICK, JA
    DECKERS, PJ
    FEDERATION PROCEEDINGS, 1976, 35 (03) : 312 - 312
  • [43] EFFECT OF CHEMOTHERAPY AND IMMUNOTHERAPY ON TUMOR-SPECIFIC IMMUNITY IN MELANOMA
    MITCHELL, MS
    MOKYR, MB
    DAVIS, JM
    JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (06): : 1017 - 1026
  • [44] EVIDENCE FOR TUMOR-SPECIFIC IMMUNITY IN HUMAN MALIGNANT MELANOMA
    NAGEL, GA
    PIESSENS, WF
    STILMANT, MM
    LEJEUNE, F
    EUROPEAN JOURNAL OF CANCER, 1971, 7 (01) : 41 - +
  • [45] RNA MEDIATED IMMUNITY TO TUMOR-SPECIFIC TRANSPLANTATION ANTIGENS
    RAMMING, KP
    PILCH, YH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1970, 11 : 65 - &
  • [46] TRANSFER OF HUMAN TUMOR-SPECIFIC IMMUNITY INVITRO WITH RNA
    WANG, BS
    MANNICK, JA
    DECKERS, PJ
    CLINICAL RESEARCH, 1976, 24 (04): : A608 - A608
  • [47] TUMOR-SPECIFIC TRANSPLANTATION IMMUNITY TO SPONTANEOUS MOUSE TUMORS
    HAMMOND, WG
    FISHER, JC
    ROLLEY, RT
    SURGERY, 1967, 62 (01) : 124 - &
  • [48] TUMOR-SPECIFIC IMMUNITY IN PATIENTS WITH MALIGNANT-MELANOMA
    ARLEN, M
    HOLLINSHEAD, A
    SCHERRER, J
    SURGICAL FORUM, 1977, 28 : 168 - 169
  • [49] Tumor mRNA–loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
    Tsutomu Kobayashi
    Ryuya Yamanaka
    Junpei Homma
    Naoto Tsuchiya
    Naoki Yajima
    Seiichi Yoshida
    Ryuichi Tanaka
    Cancer Immunology, Immunotherapy, 2003, 52 : 632 - 637
  • [50] Targeting tumor-specific T cells
    HOWES, L. A. U. R. A.
    CHEMICAL & ENGINEERING NEWS, 2020, 98 (41) : 7 - 7